Author

Margaret Masterson

Rutgers, The State University of New JerseyORCID 0000-0002-2544-4930Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrey S. DobroffiD· 1 shared Brian K. MannakeeiD· 1 shared Christy A. Tarleton· 1 shared Ethan S. SokoliD· 1 shared Gregory RiedlingeriD· 1 shared Ian RabinowitziD· 1 shared Joyce E. BischoffiD· 1 shared Julie Y. TseiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Andrey S. DobroffORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genomic Landscape of Lymphatic Malformations: A Case Series and Response to the PI3Kα Inhibitor Alpelisib in an N-of-One Clinical Trial

Montaser F. Shaheen, Julie Y. Tse, Ethan S. Sokol, Margaret Masterson, Pranshu Bansal, Ian Rabinowitz, Christy A. Tarleton, Andrey S. Dobroff, Tracey L. Smith, Therese J. Bocklage, Brian K. Mannakee, Ryan N. Gutenkunst, Joyce E. Bischoff, Scott A. Ness, Gregory Riedlinger, , Wadih Arap

This paper reports the genomic profile of lymphatic malformations, identifies PIK3CA and NRAS mutations, and shows a response to the PI3K inhibitor alpelisib in a personalized trial.

eLife · Jun 16, 2022Peer-reviewedGenetic & Genomic Medicine